Talus Bioscience announced it raised $9.42 Million in an initial filing from an offering of $11.3 Million
Talus Bioscience announced it raised $9.42 Million in an initial filing from an offering of $11.3 Million
08/12/24, 8:01 PM
Location
seattleMoney raised
$9.42 million
Industry
information technology
Company Info
Location
550 17th avenue, suite 550
seattle, washington, united states
Additional Info
Talus Bioscience is a venture-backed early-stage biotechnology startup company working on drug development for gene regulators. Talus Bio spun out of two leading institutions in September 2020 (University of Washington and Altius Institute for Biomedical Sciences) and is located in Seattle, WA. We are building a data-enabled drug development platform that will focus primarily on small-molecule drug development in oncology.